Background Only 15–20% of patients with chronic hepatitis C achieve a sustained virological
response with interferon therapy. The aim of this study was to compare the efficacy and …

Hyperlipidemia is a known risk factor for fatty infiltration of the liver, a condition that can
progress to cirrhosis and liver failure. The objectives of this study were to document the …

Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal
amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile …

Background: The efficacy of nucleoside and nucleotide analogues for hepatitis B has been
linked to the magnitude and durability of hepatitis B virus (HBV) suppression. Objective: To …

Hepatitis B virus (HBV) infections continue to occur in adult hemodialysis units. A possible
contributing factor is the presence of occult HBV (serum hepatitis B surface antigen [HBsAg] …

The trigger of the liver regeneration cascade is currently unknown and has been the subject
of debate. We hypothesize that, following 2/3 partial hepatectomy (PHX), an increase in the …

BACKGROUND/AIMS: Occult hepatitis B virus (HBV) infection [HBV-DNA detection in hepatitis
B surface antigen (HBsAg)-negative individuals] may cause acute and/or chronic liver …

Liver fatty acid binding protein (L‐FABP) contains amino acids that are known to possess
antioxidant function. In this study, we tested the hypothesis that L‐FABP may serve as an …

To dispel the common notion that the practice of hepatology in North America largely consists
of the care of middle–aged male patients with alcohol–induced liver disease, and, in the …

Determining the longitudinal molecular evolution of hepatitis B virus (HBV) is difficult due to
HBV's genomic complexity and the need to study paired samples collected over long periods …